Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more

Atomera Provides Third Quarter 2026 Results

By PR Newswire | October 29, 2026, 4:01 PM

LOS GATOS, Calif., Oct. 29, 2026 /PRNewswire/ -- ­­ Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2026.

Atomera

Recent Company Highlights

  • Increased engagement count to three customers in gate-all-around
  • Signed a Joint Development Agreement with IQE to bring high-performance, cost-effective RF GaN to market
  • Demonstrated simpler, lower cost approach to enable next-generation DRAM transistors with MST

Management Commentary

"This quarter we expanded our customer engagements in the advanced logic and memory segments, where AI continues to drive the need for higher transistor performance. Our ground-breaking nano-scale diffusion blocking work for gate-all-around transistors has generated interest not only with the GAA foundries, but also with designers of next generation memory solutions" said Scott Bibaud, president and CEO of Atomera. "While work in our traditional business is taking off, we also took an important step toward commercializing our GaN-on-silicon solutions by signing a joint development agreement with IQE, a leading supplier of compound semiconductor wafers."

Financial Results

The Company incurred a net loss of ($6.0) million, or ($0.15) per basic and diluted share in the third quarter of 2026, compared to a net loss of ($5.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2026 was a loss of ($4.6) million compared to an adjusted EBITDA loss of ($4.4) million in the third quarter of 2025.

The Company had $34.8 million in cash, cash equivalents and short-term investments as of Sept. 30, 2026, compared to $19.2 million as of December 31, 2025. 

The total number of shares outstanding was 39.1 million as of September 30, 2026.

Third Quarter 2026 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Thursday, Oct. 29, 2026

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com 

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com. 

Safe Harbor

 This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-­looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and know-­how and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow –

Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)





















September 30,





December 31,







2026





2025







(Unaudited)











ASSETS



































Current assets:

















Cash and cash equivalents



$

23,268





$

19,210



Short-term investments





11,560







–



Interest receivable





152







54



Prepaid expenses and other current assets





456







338



Total current assets





35,436







19,602





















Property and equipment, net





62







60



Security deposit





14







14



Operating lease right-of-use asset





2,731







884



Financing lease right-of-use-asset





196







533





















Total assets



$

38,439





$

21,093





















LIABILITIES AND STOCKHOLDERS' EQUITY



































Current liabilities:

















Accounts payable



$

868





$

608



Accrued expenses





522







168



Accrued payroll related expenses





1,326







650



Current operating lease liability





1,908







147



Current financing lease liability





198







420



Deferred Revenue





–







7



Total current liabilities





4,822







2,000





















Long-term operating lease liability





823







712





















Total liabilities





5,645







2,712





















Commitments and contingencies





–







–





















Stockholders' equity:





–







–



Preferred stock $0.001 par value, authorized 2,500 shares; none issued and

     outstanding as of September 30, 2026 and December 31, 2025

















Common stock: $0.001 par value, authorized 95,000 shares; 39,083 shares issued and 

     outstanding as of September 30, 2026; and 32,354 shares issued and outstanding as

     of December 31, 2025





39







32



Additional paid in capital





292,874







260,043



Other comprehensive income (loss)





(10)







–



Accumulated deficit





(260,109)







(241,694)



Total stockholders' equity





32,794







18,381



Total liabilities and stockholders' equity



$

38,439





$

21,093



 

Atomera Incorporated

Condensed Statements of Operations

(Unaudited)

(in thousands, except per share data)





















































Three Months Ended





Nine Months Ended













September 30,



June 30,







September 30,





September 30,











2026



2026







2025





2026





2025





Revenue



$

–



$



158







$

11





$

169





$

15



Cost of revenue





–







(26)









(128)







(152)







(190)



Gross margin





–







132









(117)







17







(175)















































Operating expenses











































Research and development





3,647







3,287









3,304







10,391







9,563



General and administrative





2,338







3,167









2,165







7,838







6,301



Selling and marketing





343







437









207







1,199







472



Total operating expenses





6,328







6,891









5,676







19,428







16,336















































Loss from operations





(6,328)







(6,759)









(5,793)







(19,411)







(16,511)















































Other income (expense)











































Interest income





254







172









232







623







736



Accretion income





75







178









–







310







6



Interest expense





(7)







(1)









(12)







(12)







(51)



Other income, net





–







74









–







75







71



Total other income, net





322







423









220







996







762















































Net loss



$

(6,006)



$



(6,336)







$

(5,573)





$

(18,415)





$

(15,749)















































Net loss per common share, basic and diluted



$

(0.15)



$



(0.17)







$

(0.17)





$

(0.49)





$

(0.51)















































Weighted average number of common shares

     outstanding, basic and diluted





38,899







38,647









31,128







37,614







30,593



 

Atomera Incorporated

Reconciliation to Non-GAAP EBITDA

(Unaudited)



















































Three Months Ended





Nine Months Ended











September 30,



June 30,







September 30,





September 30,







2026



2026







2025





2026





2025



Net loss (GAAP)



$

(6,006)



$



(6,336)







$

(5,573)





$

(18,415)





$

(15,749)





Depreciation and amortization





10







6









11







25







35





Stock-based compensation





1,746







1,741









1,342







4,893







3,629





Interest income





(254)







(172)









(232)







(623)







(736)





Accretion income





(75)







(178)









–







(310)







(6)





Interest expense





7







1









12







12







51





Other income, net





–







(74)









–







(75)







(71)





Net loss non-GAAP EBITDA



$

(4,572)



$



(5,012)







$

(4,440)





$

(14,493)





$

(12,847)





 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/atomera-provides-third-quarter-2026-results-302924164.html

SOURCE Atomera Incorporated

Mentioned In This Article

Latest News

Oct-30
Oct-29
Oct-22
Oct-19
Aug-05
Aug-04
Aug-04
Jul-21
Jun-04
May-05
Apr-23
Apr-22
Apr-21
Apr-09
Mar-17